New class action for Klarna Group plc (KLAR) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/20/2026.

image for news Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Varonis Systems (VRNS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/9/2026.

image for news Bronstein, Gewirtz & Grossman LLC Urges Varonis Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired SLM securities between July 25, 2025 and August 14, 2025, both dates inclusive (the “Class Period”).

image for news Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, will showcase its latest AI-driven hardware, software, and services at NRF 2026: Retail's Big Show. Zebra's solutions will be featured in Booth #3303 from Jan. 11–13, 2026 at the Jacob K. Javits Convention Center in New York City. As retailers navigate a competitive landscape, they face growing pressures to meet rising cons.

image for news Zebra Technologies Empowers Retail Frontline Operations with Advanced AI-Powered Solutions

RALEIGH, N.C.--(BUSINESS WIRE)--Advance Auto Parts Names OSRAM Sylvania Inc. Global 2025 Vendor Partner of the Year.

image for news Advance Auto Parts Names OSRAM Sylvania Inc. Global 2025 Vendor Partner of the Year

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options

image for news TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

European Defense Stocks Rally. 3 Particularly Bullish Charts. — Positive

GD  LMT  NOC  RTX   Barrons — January 09, 2026

A German contractor, Italian aerospace name, and British defense company.

image for news European Defense Stocks Rally. 3 Particularly Bullish Charts.

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares”) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000 (the “Offering”). In connection with the Offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 291,750 Common Shares at the public offering price, less underwriting discounts and commissions. All of the securities sold in this Offering were offered by …

image for news Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

I'm Upgrading Karooooo To A Buy On Profitable Revenue Growth — Positive

KARO   Seeking Alpha — January 09, 2026

I'm ugrading Karooooo Ltd. to a Buy on accelerating, profitable revenue growth and disciplined cost management. KARO's Logistics segment is outpacing Cartrack in its growth rate, driven by e-commerce and high customer retention, supporting a robust LTV to CAC of over 9x. Management highlights strong demand exceeding current onboarding capacity, with strategic expansion in Southeast Asia and Europe underway.

image for news I'm Upgrading Karooooo To A Buy On Profitable Revenue Growth

4 Stocks to Boost Your Portfolio on Steady Jump in Semiconductor Sales — Positive

ADI  ASYS  MTSI  NVDA   Zacks Investment Research — January 09, 2026

Rising global chip sales and AI-driven demand put ADI, NVDA, MTSI and ASYS in focus as semiconductor stocks gain momentum in a strong market.

image for news 4 Stocks to Boost Your Portfolio on Steady Jump in Semiconductor Sales

J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve — Positive

JNJ   Zacks Investment Research — January 09, 2026

JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.

image for news J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve

SENS Stock Up as Eversense 365 Enters AID Market With twiist System — Positive

SENS   Zacks Investment Research — January 09, 2026

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

image for news SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Why PBF Energy Stock Is Surging On Venezuela Catalyst — Positive

PBF   Forbes — January 09, 2026

PBF Energy soared 14% on a robust gap-and-go following a Piper Sandler upgrade to ‘Overweight' accompanied by a $40 price target. The catalyst mentioned was PBF‘s strategic advantage in increasing Venezuelan crude imports.

image for news Why PBF Energy Stock Is Surging On Venezuela Catalyst

Focus: Banks eye Venezuela investment, JPMorgan seen with advantage — Positive

C  JPM   Reuters — January 09, 2026

The U.S. involvement in Venezuela's oil sector offers a potential opportunity for international banks, with JPMorgan Chase in an advantageous spot due to its history in the country and past involvement with international trade financing.

image for news Focus: Banks eye Venezuela investment, JPMorgan seen with advantage

India ETFs Offer Compelling Growth Upside: Is the Risk Worth Taking? — Positive

EPI  FLIN  INDA  INDY  NFTY   Zacks Investment Research — January 09, 2026

Despite tariff worries and equity outflows, India's growth story makes its ETFs a compelling play.

image for news India ETFs Offer Compelling Growth Upside: Is the Risk Worth Taking?

Navient's Leadership Changes: How Will it Impact Future Growth? — Positive

NAVI   Zacks Investment Research — January 09, 2026

In a move to align management responsibilities with its evolving business strategy, Navient Corporation NAVI has revised its leadership structure. As part of the move, Steve Hauber, previously executive vice president (EVP) and chief administrative officer, has been appointed EVP and chief financial officer (CFO), effective immediately.

image for news Navient's Leadership Changes: How Will it Impact Future Growth?

What Postal Realty Trust's 2025 Update Means for Investors — Positive

PSTL   Zacks Investment Research — January 09, 2026

PSTL's 2025 results show steady expansion, with 216 USPS-leased property buys, near-100% occupancy and a fixed-rate balance sheet.

image for news What Postal Realty Trust's 2025 Update Means for Investors

Reasons Why You Should Hold Verisk Analytics Stock in Your Portfolio — Positive

VRSK   Zacks Investment Research — January 09, 2026

VRSK shares beat industry gains as subscription shift, SaaS demand and new AI tools drive revenue growth across underwriting and claims.

image for news Reasons Why You Should Hold Verisk Analytics Stock in Your Portfolio

NEW YORK--(BUSINESS WIRE)---- $AQST #AQST--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. Shares of Aquestive Therapeutics, Inc. (NA.

image for news INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

Biotech outperformance expected to continue in 2026, Baird analysts say — Positive

OCUL   Proactive Investors — January 09, 2026

The biotechnology sector's strong fundamentals and robust innovation could continue to drive outperformance this year, according to Baird analysts. The firm noted that while macroeconomic risks such as rising interest rates remain, the biotechnology sector's underlying drivers are supportive.

image for news Biotech outperformance expected to continue in 2026, Baird analysts say